Ligand Pharmaceuticals
LGND
C$185.34
Share price
-0.67%
Change (1 day)
23.00%
Change (1 year)
EPS for Ligand Pharmaceuticals (LGND)
EPS in 2025 (TTM): C-$10.00
According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is C-$9.78. In 2024 the company made an earnings per share (EPS) of C-$0.06869 a decrease over its 2023 EPS that were of C$3.97.
EPS history for Ligand Pharmaceuticals from 2012 to 2025
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2025 (TTM) | C-$10.00 | 14457.57% |
| 2024 | C-$0.06869 | -101.73% |
| 2023 | C$3.97 | -245.96% |
| 2022 | C-$2.72 | -157.23% |
| 2021 | C$4.75 | -2571.43% |
| 2020 | C-$0.19 | -100.46% |
| 2019 | C$42.05 | 353.48% |
| 2018 | C$9.27 | 1025% |
| 2017 | C$0.82 | -700% |
| 2016 | C-$0.14 | -100.87% |
| 2015 | C$15.88 | 1859.32% |
| 2014 | C$0.81 | 5.36% |
| 2013 | C$0.77 | 8.0704505322479E+18% |
| 2012 | C$0.0000000000 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | C$15.18 | -255.20% | 🇺🇸 USA |
 Spectrum Pharmaceuticals
SPPI | C-$0.49 | -94.94% | 🇺🇸 USA |
 GlaxoSmithKline GSK | C$2.14 | -121.91% | 🇬🇧 UK |
 Merck MRK | C$9.48 | -196.87% | 🇺🇸 USA |
 Pfizer PFE | C$1.91 | -119.52% | 🇺🇸 USA |
 Eli Lilly LLY | C$16.97 | -273.54% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | C$3.68 | -137.64% | 🇺🇸 USA |
 Baxter BAX | C-$0.04121 | -99.58% | 🇺🇸 USA |
 Johnson & Johnson JNJ | C$12.46 | -227.35% | 🇺🇸 USA |